ECLIPSE MEDICAL LEGAL LTDActive

Company number 07030948Private limited companyIncorporated 2009
⚠ Confirmation statement overdue. It was due on 20 Sep 2026.

Key figures

−£6,549-359.5%
Net assets 2024/25
-50 k050 k100 k150 k2019/202020/212021/222022/232023/242024/25

Like most small UK companies, ECLIPSE MEDICAL LEGAL LTD does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2024/25
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
0200 k400 k600 k2019/202020/212021/222022/232023/242024/25
Filed accounts2019/20–2024/25
2020/212021/222022/232023/242024/25
Cash at bank and in hand462,025117,14964,72263,62562,180
Total assets465,127235,212178,411177,245176,400
Total liabilities347,413165,027169,222174,721182,949
Net assets / total equity118,24970,1859,1892,524-6,549
Average number of employees00000

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: ECLIPSE MEDICAL LEGAL LTD

Company

ECLIPSE MEDICAL LEGAL LTD is a private limited company registered with Companies House under company number 07030948. It was incorporated on 26 Sep 2009. Its status is active. The registered office is in Bradford (BD8). Its nature of business (SIC 2007) is other service activities n.e.c. (96090).

Accounts

The latest accounts in the database are for 2024/25 (period ending 30 Sep 2025); the company files small company accounts (filleted). Net assets were −£6,549, down 359.5% on the previous year. Cash at bank and in hand was £62,180. Total assets were £176,400 and total liabilities £182,949. The company had an average of 0 employees. Figures are available for 6 financial years (2019/20–2024/25).

Control and charges

One person with significant control is registered.

Filing deadlines

The next accounts are due by 30 Jun 2027. The next confirmation statement is due by 20 Sep 2026.